SCHEMBL3482698

SCHEMBL3482698

CCOC(=O)/C(=C/C(=O)O)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.54
MAPT P10636 6/20 0.54
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
SMN1; SMN2 Q16637 2/20 0.48
LMNA P02545 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
NPC1 O15118 1/20 0.46
GAA P10253 1/20 0.45
KDM4E B2RXH2 2/20 0.45
HSP90AA1 P07900 1/20 0.44
HPGD P15428 1/20 0.44
CYP19A1 P11511 2/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA9 Q16790 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6394012 1.00 ALDH1A1 (0.54) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL11274535 1.00 ALDH1A1 (0.54) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL7992908 0.88 MAPT (0.53) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL4911670 0.88 MAPT (0.53) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL13761867 0.88 ALDH1A1 (0.53) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL4911666 0.88 MAPT (0.53) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL9364404 0.87 ALDH1A1 (0.51) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL9364405 0.87 ALDH1A1 (0.51) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL6388157 0.87 ESR1 (0.54) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL28619132 0.86 ALDH1A1 (0.57) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420764-B2 Compound having silsesquioxane skeleton and its polymer JNC CORPORATION (JP) 2013-04-16 US disclosed
US-20120178894-A1 COMPOUND HAVING SILSESQUIOXANE SKELETON AND ITS POLYMER INAGAKI JYUN-ICHI (JP) 2012-07-12 US disclosed
US-7705105-B2 A cyclic polymer of silsesquioxane skeleton with side chains formed byhydrosilation of an unsaturated end group containing an active polymerfunctional group; polyimidesiloxane copolymers; polyestersiloxane copolymers; high molecular weight; thin films; strength; heat resistance;waterproofing; CHISSO PETROCHEMICAL CORPORATION (JP) 2010-04-27 US disclosed
US-20070190344-A1 Verification of translation JNC CORPORATION (JP) 2007-08-16 US disclosed
US-20050009982-A1 Compound having silsesquioxane skeleton and its polymer CHISSO CORPORATION (JP) 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009982-A1 Compound having silsesquioxane skeleton and its polymer C1S, H1-4, H1-0 ALDH1A1 1780/4885MAPT 3028/4885MEN1 575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.